{Reference Type}: Case Reports
{Title}: Discrepancy between Multiparametric Magnetic Resonance Imaging and 68Ga Prostate-Specific Membrane Antigen Positron Emission Tomography: A Simultaneous Acquired Positron Emission Tomography-Magnetic Resonance Imaging Case.
{Author}: Moolan NJ;Somasundaram VH;Rajamma BM;Sundaram PS;
{Journal}: Indian J Nucl Med
{Volume}: 36
{Issue}: 1
{Year}: Jan-Mar 2021
暂无{DOI}: 10.4103/ijnm.IJNM_115_20
{Abstract}: Conventionally, multiparametric magnetic resonance imaging (mpMRI) incorporating T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences is considered the standard for detection and staging of clinically important prostate cancer (PCa).[1] The 68gallium (68Ga)-labeled positron emission tomography (PET) tracer targeting prostate-specific membrane antigen (PSMA), 68Ga-PSMA PET, is a promising tool for detection, localization, and staging carcinoma prostate.[2] Here, we present a case of PCa, showing incongruence between 68Ga-PSMA PET and the corresponding mpMRI findings. Moreover, the final histopathology revealed a surprise, which exemplifies the complementary nature of combining 68Ga-PSMA PET and mpMRI in the diagnosis and staging of carcinoma prostate.